SEC Form 4 research
| Issuer | Vir Biotechnology, Inc. |
|---|---|
| Tickers | VIR |
| Reporting owners | 55 |
| Officers and directors | 21 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-03 | de Verneuil Vanina | S | 2,407 | $11.1 | Not reported |
| 2026-11-04 | 2026-11-02 | de Verneuil Vanina | S | 1,343 | $11.33 | Not reported |
| 2026-10-28 | 2026-10-27 | Topalian Suzanne Louise | A | 4,731 | $0 | Not reported |
| 2026-10-28 | 2026-10-27 | Topalian Suzanne Louise | A | 9,462 | $0 | Not reported |
| 2026-10-28 | 2026-10-27 | Topalian Suzanne Louise | A | 8,000 | $0 | Not reported |
| 2026-10-28 | 2026-10-27 | Topalian Suzanne Louise | A | 16,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.